Paz-Ares LG, Carbone DP. Response to the Letter to the Editor Titled "First-Line Nivolumab Plus Ipilimumab With Chemotherapy for Metastatic NSCLC: The Updated Outcomes From CheckMate 9LA". J Thorac Oncol 2023;18:e102-e103.
PMID: 37599049